4-way Crossover QT Evaluation in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 11, 2018

Primary Completion Date

April 12, 2018

Study Completion Date

August 21, 2018

Conditions

Cardiac Repolarization in Healthy Subjects

Interventions

DRUG

ZTI-01

6g IV fosfomycin

DRUG

Moxifloxacin 400mg

oral moxifloxacin (Avelox 400 mg) + IV normal saline (Placebo)

OTHER

Placebo IV

IV Placebo (0.9% Normal Saline)

Trial Locations (1)

Pharmaron, Baltimore